HK Stock MarketDetailed Quotes

02235 MICROTECH MED-B

Watchlist

4.050
+0.050+1.25%

Market Closed Apr 26 16:08 CST

1.72BMarket Cap-12500P/E (TTM)

MICROTECH MED-B Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Cash flow from operating activities

Earning before tax

----

60.29%-48.15M

---19.06M

-54.23%-121.25M

---78.61M

Profit adjustment

Interest (income) - adjustment

----

-881.31%-23.32M

---9.4M

-180.19%-2.38M

---848K

Investment loss (gain)

----

---5.77M

----

Impairment and provisions:

--0

504.08%1.78M

--641K

-50.75%294K

--597K

-Impairmen of inventory (reversal)

----

416.04%547K

--298K

-39.08%106K

--174K

-Impairment of trade receivables (reversal)

----

553.72%1.23M

--343K

-55.56%188K

--423K

Revaluation surplus:

--0

Asset sale loss (gain):

--0

80.18%-45K

--0

-266.13%-227K

---62K

-Loss (gain) on sale of property, machinery and equipment

----

80.18%-45K

----

-266.13%-227K

---62K

Depreciation and amortization:

--0

51.93%8.33M

--3.94M

59.88%5.48M

--3.43M

-Depreciation

----

73.25%6.55M

--3.09M

91.59%3.78M

--1.97M

-Amortization of intangible assets

----

4.64%1.78M

--844K

16.95%1.7M

--1.46M

Financial expense

----

-94.48%17K

--2K

-0.96%308K

--311K

Exchange Loss (gain)

----

682.01%16.48M

--864K

1,232.80%2.11M

---186K

Special items

----

-89.87%11.26M

--11.47M

113.02%111.18M

--52.19M

Operating profit before the change of operating capital

--0

-228.24%-33.65M

---11.55M

55.78%-10.25M

---23.18M

Change of operating capital

Inventory (increase) decrease

----

-64.69%-16.29M

---5.34M

-374.39%-9.89M

---2.09M

Accounts receivable (increase)decrease

----

-426.70%-18.64M

---5.41M

-19.08%-3.54M

---2.97M

Accounts payable increase (decrease)

----

310.12%22.58M

--3.98M

-25.54%5.51M

--7.39M

prepayments (increase)decrease

----

-3,444.98%-15.99M

--332K

133.43%478K

---1.43M

Cash from business operations

--0

-465.07%-67.53M

---19.23M

36.44%-11.95M

---18.8M

Interest received - operating

----

881.31%23.32M

--9.4M

180.19%2.38M

--848K

Special items of business

----

-196.38%-5.54M

---1.25M

65.46%5.75M

--3.47M

Net cash from operations

-28.56%-153M

-20.21%-31.8M

-169.16%-119.01M

-169.21%-26.46M

-361.79%-44.22M

---9.83M

46.67%-9.58M

---17.95M

Cash flow from investment activities

Loan receivable (increase) decrease

----

200.00%10M

---10M

Decrease in deposits (increase)

----

200.00%10M

--10M

---10M

----

Sale of fixed assets

----

-88.46%45K

----

529.03%390K

--62K

Purchase of fixed assets

3.64%-28.7M

71.31%-4.02M

-69.22%-29.78M

-136.11%-14.01M

31.40%-17.6M

---5.94M

10.21%-25.66M

---28.57M

Purchase of intangible assets

----

-3,907.14%-1.12M

---182K

98.56%-28K

---1.95M

Recovery of cash from investments

----

-51.56%106.36M

--95.92M

42.56%219.57M

--154.02M

Cash on investment

----

6.32%-195.5M

---208.7M

Other items in the investment business

-42.36%-512.01M

---425.09M

---359.66M

----

Net cash from investment operations

-38.84%-540.7M

-2,962.24%-429.11M

-498.66%-389.44M

-114.04%-14.01M

8,094.11%97.69M

--99.81M

98.72%-1.22M

---95.14M

Net cash before financing

-36.43%-693.7M

-1,038.96%-460.91M

-1,050.88%-508.46M

-144.98%-40.47M

595.25%53.47M

--89.98M

90.45%-10.8M

---113.1M

Cash flow from financing activities

New borrowing

----

0.00%10M

--10M

Refund

----

---20M

----

Issuing shares

----

--1.66B

----

Interest paid - financing

----

94.69%-17K

---2K

-7.02%-320K

---299K

Absorb investment income

----

467.79%521.8M

--91.9M

Issuance expenses and redemption of securities expenses

----

---83.01M

---10.13M

----

Other items of the financing business

-14.06%-23.46M

98.64%-283K

-11,791.64%-20.57M

-50,595.12%-20.79M

15.61%-173K

---41K

71.72%-205K

---725K

Net cash from financing operations

-14.06%-23.46M

98.64%-283K

-101.31%-20.57M

-104.34%-20.79M

207.89%1.57B

---10.17M

406.84%511.28M

--100.88M

Effect of rate

-106.08%-1.65M

-76.90%3.24M

264.47%27.1M

1,721.88%14.01M

-682.01%-16.48M

---864K

-1,232.80%-2.11M

--186K

Net Cash

-43.21%-718.81M

-869.43%-457.96M

-130.84%-501.93M

-159.19%-47.24M

225.22%1.63B

--79.81M

4,195.91%500.48M

---12.22M

Begining period cash

-31.64%1.08B

-49.59%1.08B

193.85%1.59B

298.48%2.15B

1,202.98%539.8M

--539.8M

-22.51%41.43M

--53.46M

Cash at the end

-66.30%365.44M

-70.23%626.29M

-49.59%1.08B

240.00%2.1B

298.48%2.15B

--618.74M

1,202.98%539.8M

--41.43M

Cash balance analysis

Cash and cash equivalent balance

--0

Currency Unit

CNY

Accounting Standards

CAS (2007)

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

Ernst & Young

	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax	----	----	----	----	60.29%-48.15M	---19.06M	-54.23%-121.25M	---78.61M
Profit adjustment
Interest (income) - adjustment	----	----	----	----	-881.31%-23.32M	---9.4M	-180.19%-2.38M	---848K
Investment loss (gain)	----	----	----	----	----	----	---5.77M	----
Impairment and provisions:	--0	--0	--0	--0	504.08%1.78M	--641K	-50.75%294K	--597K
-Impairmen of inventory (reversal)	----	----	----	----	416.04%547K	--298K	-39.08%106K	--174K
-Impairment of trade receivables (reversal)	----	----	----	----	553.72%1.23M	--343K	-55.56%188K	--423K
Revaluation surplus:	--0	--0	--0	--0	--0	--0	--0	--0
Asset sale loss (gain):	--0	--0	--0	--0	80.18%-45K	--0	-266.13%-227K	---62K
-Loss (gain) on sale of property, machinery and equipment	----	----	----	----	80.18%-45K	----	-266.13%-227K	---62K
Depreciation and amortization:	--0	--0	--0	--0	51.93%8.33M	--3.94M	59.88%5.48M	--3.43M
-Depreciation	----	----	----	----	73.25%6.55M	--3.09M	91.59%3.78M	--1.97M
-Amortization of intangible assets	----	----	----	----	4.64%1.78M	--844K	16.95%1.7M	--1.46M
Financial expense	----	----	----	----	-94.48%17K	--2K	-0.96%308K	--311K
Exchange Loss (gain)	----	----	----	----	682.01%16.48M	--864K	1,232.80%2.11M	---186K
Special items	----	----	----	----	-89.87%11.26M	--11.47M	113.02%111.18M	--52.19M
Operating profit before the change of operating capital	--0	--0	--0	--0	-228.24%-33.65M	---11.55M	55.78%-10.25M	---23.18M
Change of operating capital
Inventory (increase) decrease	----	----	----	----	-64.69%-16.29M	---5.34M	-374.39%-9.89M	---2.09M
Accounts receivable (increase)decrease	----	----	----	----	-426.70%-18.64M	---5.41M	-19.08%-3.54M	---2.97M
Accounts payable increase (decrease)	----	----	----	----	310.12%22.58M	--3.98M	-25.54%5.51M	--7.39M
prepayments (increase)decrease	----	----	----	----	-3,444.98%-15.99M	--332K	133.43%478K	---1.43M
Cash from business operations	--0	--0	--0	--0	-465.07%-67.53M	---19.23M	36.44%-11.95M	---18.8M
Interest received - operating	----	----	----	----	881.31%23.32M	--9.4M	180.19%2.38M	--848K
Special items of business	----	----	----	----	-196.38%-5.54M	---1.25M	65.46%5.75M	--3.47M
Net cash from operations	-28.56%-153M	-20.21%-31.8M	-169.16%-119.01M	-169.21%-26.46M	-361.79%-44.22M	---9.83M	46.67%-9.58M	---17.95M
Cash flow from investment activities
Loan receivable (increase) decrease	----	----	----	----	----	----	200.00%10M	---10M
Decrease in deposits (increase)	----	----	----	----	200.00%10M	--10M	---10M	----
Sale of fixed assets	----	----	----	----	-88.46%45K	----	529.03%390K	--62K
Purchase of fixed assets	3.64%-28.7M	71.31%-4.02M	-69.22%-29.78M	-136.11%-14.01M	31.40%-17.6M	---5.94M	10.21%-25.66M	---28.57M
Purchase of intangible assets	----	----	----	----	-3,907.14%-1.12M	---182K	98.56%-28K	---1.95M
Recovery of cash from investments	----	----	----	----	-51.56%106.36M	--95.92M	42.56%219.57M	--154.02M
Cash on investment	----	----	----	----	----	----	6.32%-195.5M	---208.7M
Other items in the investment business	-42.36%-512.01M	---425.09M	---359.66M	----	----	----	----	----
Net cash from investment operations	-38.84%-540.7M	-2,962.24%-429.11M	-498.66%-389.44M	-114.04%-14.01M	8,094.11%97.69M	--99.81M	98.72%-1.22M	---95.14M
Net cash before financing	-36.43%-693.7M	-1,038.96%-460.91M	-1,050.88%-508.46M	-144.98%-40.47M	595.25%53.47M	--89.98M	90.45%-10.8M	---113.1M
Cash flow from financing activities
New borrowing	----	----	----	----	----	----	0.00%10M	--10M
Refund	----	----	----	----	----	----	---20M	----
Issuing shares	----	----	----	----	--1.66B	----	----	----
Interest paid - financing	----	----	----	----	94.69%-17K	---2K	-7.02%-320K	---299K
Absorb investment income	----	----	----	----	----	----	467.79%521.8M	--91.9M
Issuance expenses and redemption of securities expenses	----	----	----	----	---83.01M	---10.13M	----	----
Other items of the financing business	-14.06%-23.46M	98.64%-283K	-11,791.64%-20.57M	-50,595.12%-20.79M	15.61%-173K	---41K	71.72%-205K	---725K
Net cash from financing operations	-14.06%-23.46M	98.64%-283K	-101.31%-20.57M	-104.34%-20.79M	207.89%1.57B	---10.17M	406.84%511.28M	--100.88M
Effect of rate	-106.08%-1.65M	-76.90%3.24M	264.47%27.1M	1,721.88%14.01M	-682.01%-16.48M	---864K	-1,232.80%-2.11M	--186K
Net Cash	-43.21%-718.81M	-869.43%-457.96M	-130.84%-501.93M	-159.19%-47.24M	225.22%1.63B	--79.81M	4,195.91%500.48M	---12.22M
Begining period cash	-31.64%1.08B	-49.59%1.08B	193.85%1.59B	298.48%2.15B	1,202.98%539.8M	--539.8M	-22.51%41.43M	--53.46M
Cash at the end	-66.30%365.44M	-70.23%626.29M	-49.59%1.08B	240.00%2.1B	298.48%2.15B	--618.74M	1,202.98%539.8M	--41.43M
Cash balance analysis
Cash and cash equivalent balance	--0	--0	--0	--0	--0	--0	--0	--0
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion
Auditor	Tianjian Certified Public Accountants (Special General Partnership)	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

02235 MICROTECH MED-B

MICROTECH MED-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target